Microdelivery device and method for enhanced drug administration to the eye

• US 5,462,739 A
• Filed: 11/02/1994
• Issued: 10/31/1995
• Est. Priority Date: 11/21/1991
• Status: Expired due to Term

• Current Assignee: Yeda Research and Development Co. Ltd. (Weizmann Institute of Science)
• Original Assignee: Yeda Research and Development Co. Ltd. (Weizmann Institute of Science)
• Inventors: Dan, Jacov, Yaron, Arieh
• Primary Examiner(s): Page, Thurman K.
• Assistant Examiner(s): Webber, Pamela S.
• Application Number:
  US08/244,248
• Time in Patent Office: 363 Days
• Field of Search: 424/427, 424/94.67, 514/912, 514/913, 514/915, 606/6, 606/4, 604/8, 604/9, 604/10, 604/294, 351/245, 351/246, 356/125, 356/127
• US Class Current: 424/427
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002

Abstract

A device for pinpoint application of micro-quantities of a pharmacologically suitable composition to the outer hard coat of the eye, comprises a micro-container with a fixation element. The micro-container comprises a bore whose aperture is adapted to contact the eye surface, and the fixation element is adapted for reversibly adhering to the eye surface.

Claims

1. A device for pinpoint application of micro-quantities of a pharmaceutical composition to a preselected portion of the outer hard coat of the eye,

the device comprising a micro-container with fixation means for reversible attachment of said micro-container to the outer hard coat of the eye adjacent to the preselected portion thereof,

said micro-container comprising a pharmaceutical composition delivery bore whose aperture is adapted to contact the preselected portion of the outer hard coat of the eye so as to expose only the preselected portion thereof to the pharmaceutical composition.

2. A device according to claim 1, wherein the micro-container and fixation means comprise a single unit.

3. A device according to claim 1, wherein the fixation means is separable from the micro-container.

4. A device according to claim 1, wherein the micro-container comprises a cylinder with a bore about 0.5 to 1.5 mm.

5. A device according to claim 1, wherein the micro-container has a volume of about 0.2 mm³ to about 1.5 mm³.

6. A device according to claim 1, wherein the micro-container comprises a removable stopper which enables filling the micro-container while it is in the state of adherence to the eye surface.

7. A device according to claim 1, wherein the thickness of a micro-container wall at its aperture is between 0.1 mm to 0.25 mm.

8. A non-invasive method for applying pharmaceutical compositions to a preselected portion of the outer hard coat of an eye at pinpoint locations, comprising the following steps:

providing a micro-container containing an amount of a pharmaceutical composition and having a pharmaceutical composition delivery bore; and

reversibly attaching the micro-container to the outer hard coat of the eye so as to locate the delivery bore in contact with said preselected portion and thereby deliver the pharmaceutical composition solely to said preselected portion.

9. A method according to claim 8, wherein the micro-container is first placed on the desired location of the eye surface and fixed thereto and subsequently a pharmaceutical composition is introduced into the micro-container.

10. A method for treating glaucoma, comprising administering, at pinpoint location on the limbus of the eye for a given time, a sufficient amount of collagenase composition to effect limited controlled tissue degradation, thereafter neutralizing the collagenase and rinsing the eye, thereby decreasing the intraocular pressure.